SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of acquisition of beneficial ownership by individuals:
SEC Accession No. 0001213900-20-033708
Filing Date
2020-10-28
Accepted
2020-10-28 16:31:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G ea129036-sc13gvivo9_tarsus.htm SC 13G 63501
  Complete submission text file 0001213900-20-033708.txt   64947
Mailing Address 192 LYTTON AVENUE PALO ALTO CA 94301
Business Address 192 LYTTON AVENUE PALO ALTO CA 94301 6506880818
Vivo Capital IX, LLC (Filed by) CIK: 0001750698 (see all company filings)

IRS No.: 824768569 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G

Mailing Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618
Business Address 15440 LAGUNA CANYON ROAD IRVINE CA 92618 (949) 409-9820
Tarsus Pharmaceuticals, Inc. (Subject) CIK: 0001819790 (see all company filings)

IRS No.: 814717861 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-91774 | Film No.: 201269046
SIC: 2836 Biological Products, (No Diagnostic Substances)